139 related articles for article (PubMed ID: 28902028)
1. A-101, a Proprietary Topical Formulation of High-Concentration Hydrogen Peroxide Solution: A Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of the Dose-Response Profile in Subjects With Seborrheic Keratosis of the Face.
DuBois JC; Jarratt M; Beger BB; Bradshaw M; Powala CV; Shanler SD
Dermatol Surg; 2018 Mar; 44(3):330-340. PubMed ID: 28902028
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w), in patients with seborrheic keratoses: Results from 2 identical, randomized, double-blind, placebo-controlled, phase 3 studies (A-101-SEBK-301/302).
Baumann LS; Blauvelt A; Draelos ZD; Kempers SE; Lupo MP; Schlessinger J; Smith SR; Wilson DC; Bradshaw M; Estes E; Shanler SD
J Am Acad Dermatol; 2018 Nov; 79(5):869-877. PubMed ID: 29864467
[TBL] [Abstract][Full Text] [Related]
3. Anatomic Site-Specific Treatment Response With 40% Hydrogen Peroxide (w/w) Topical Formulation for Raised Seborrheic Keratoses: Pooled Analysis of Data from Two Phase 3 Studies.
Smith SR; Xu S; Estes E; Shanler SD
J Drugs Dermatol; 2018 Oct; 17(10):1092-1098. PubMed ID: 30365590
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen Peroxide Topical Solution, 40% (w/w) for the Treatment of Seborrheic Keratoses: A Review.
Murphy EC; Friedman AJ
Skin Therapy Lett; 2020 Jan; 25(1):1-4. PubMed ID: 32023021
[TBL] [Abstract][Full Text] [Related]
5. Assessing Patients' Satisfaction With Hydrogen Peroxide Topical Solution, 40% for Treatment of Raised Seborrheic Keratoses.
DuBois J; Grande K; Rhodes T; Schnyder J; Shanler SD
J Drugs Dermatol; 2020 Dec; 19(12):1184-1191. PubMed ID: 33346520
[TBL] [Abstract][Full Text] [Related]
6. Hydrogen Peroxide 40% for the Treatment of Seborrheic Keratoses.
Funkhouser CH; Coerdt KM; Haidari W; Cardis MA
Ann Pharmacother; 2021 Feb; 55(2):216-221. PubMed ID: 32646224
[TBL] [Abstract][Full Text] [Related]
7. Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled Study.
Stein Gold L; Weiss J; Rueda MJ; Liu H; Tanghetti E
Am J Clin Dermatol; 2016 Jun; 17(3):293-303. PubMed ID: 26945741
[TBL] [Abstract][Full Text] [Related]
8. Clinical Experience With 40% Hydrogen Peroxide Topical Solution for the Treatment of Seborrheic Keratosis.
Peredo M; Murphy E; Karibayeva D
J Drugs Dermatol; 2019 Jul; 18(7):s173-177. PubMed ID: 31336413
[TBL] [Abstract][Full Text] [Related]
9. Comparison of efficacy and safety of 30% hydrogen peroxide with 50% trichloroacetic acid in seborrheic keratosis: a randomized controlled study.
Agrawal D; Adil M; Amin SS; Mohtashim M; Bansal R; Tabassum H
Ital J Dermatol Venerol; 2021 Aug; 156(4):489-495. PubMed ID: 32348081
[TBL] [Abstract][Full Text] [Related]
10. Enhancing Outcomes in Seborrheic Keratosis: Using a Novel Treatment Solution.
Schlesinger TE; Favre C
J Drugs Dermatol; 2019 Jul; 18(7):s178-182. PubMed ID: 31336414
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Feldman SR; Matheson R; Bruce S; Grande K; Markowitz O; Kempers S; Brundage T; Wyres M;
Am J Clin Dermatol; 2012 Aug; 13(4):261-71. PubMed ID: 22587791
[TBL] [Abstract][Full Text] [Related]
12. Eskata (40% Hydrogen Peroxide Solution) for the Treatment of Seborrheic Keratoses.
Keaney T
J Drugs Dermatol; 2019 Jul; 18(7):s172. PubMed ID: 31336412
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of topical treatments for seborrheic keratoses: a systematic review.
Natarelli N; Krenitsky A; Hennessy K; Moore S; Grichnik J
J Dermatolog Treat; 2023 Dec; 34(1):2133532. PubMed ID: 36215682
[TBL] [Abstract][Full Text] [Related]
14. Safety and efficacy of clindamycin phosphate 1.2%-benzoyl peroxide 3% fixed-dose combination gel for the treatment of acne vulgaris: a phase 3, multicenter, randomized, double-blind, active- and vehicle-controlled study.
Eichenfield LF; Alió Sáenz AB
J Drugs Dermatol; 2011 Dec; 10(12):1382-96. PubMed ID: 22134562
[TBL] [Abstract][Full Text] [Related]
15. Managing Seborrheic Keratosis: Evolving Strategies and Optimal Therapeutic Outcomes.
Kao S; Kiss A; Efimova T; Friedman AJ
J Drugs Dermatol; 2018 Sep; 17(9):933-940. PubMed ID: 30235378
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and morphological effects of hydrogen peroxide 40% topical solution for the treatment of seborrheic keratoses, evaluated by dynamic optical coherence tomography.
Forouzandeh M; Rajabi-Estarabadi A; Williams NM; Avanaki MRN; Nouri K
Skin Res Technol; 2020 Jan; 26(1):142-145. PubMed ID: 31338893
[No Abstract] [Full Text] [Related]
17. Skin tolerability and efficacy of combination therapy with hydrogen peroxide stabilized cream and adapalene gel in comparison with benzoyl peroxide cream and adapalene gel in common acne. A randomized, investigator-masked, controlled trial.
Capizzi R; Landi F; Milani M; Amerio P
Br J Dermatol; 2004 Aug; 151(2):481-4. PubMed ID: 15327558
[TBL] [Abstract][Full Text] [Related]
18. Hydrogen Peroxide Topical Solution, 45% for Common Warts: Phase 2 Efficacy and Safety Trial Results.
Smith SR; Tyring SK; Grande KK; Schlessinger J; Gold MH; Shanier SD
J Drugs Dermatol; 2020 Oct; 19(10):969-976. PubMed ID: 33026766
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen Peroxide 40% (Eskata) for Seborrheic Keratosis.
Robertson S; Franko J
Am Fam Physician; 2019 Nov; 100(10):643-644. PubMed ID: 31730314
[No Abstract] [Full Text] [Related]
20. Randomized, double-blind, double-dummy, vehicle-controlled study of ingenol mebutate gel 0.025% and 0.05% for actinic keratosis.
Anderson L; Schmieder GJ; Werschler WP; Tschen EH; Ling MR; Stough DB; Katsamas J
J Am Acad Dermatol; 2009 Jun; 60(6):934-43. PubMed ID: 19467365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
